Rating Rationale
August 04, 2022 | Mumbai
Assam Bio Refinery Private Limited
Rating reaffirmed at 'CRISIL A+/Negative'; rated amount enhanced for Bank Debt
 
Rating Action
Total Bank Loan Facilities RatedRs.2170 Crore (Enhanced from Rs.1225 Crore)
Long Term RatingCRISIL A+/Negative (Reaffirmed)
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings has reaffirmed its ‘CRISIL A+/Negative’ rating on the long-term bank facilities of Assam Bio Refinery Private Limited (ABRPL).

 

The rating continues to factor that the company’s credit risk profile may weaken over the medium term, in case of a further escalation in the project cost or implementation timelines. Earlier, due to changes required in project scope coupled with cost and time overruns incurred, the total project cost was revised to Rs. 3,250 crores as compared to the initial estimates of Rs. 1,750 crores. The project commissioning timelines were also delayed by a year to April 2023. While the management does not anticipate any further escalations in the project cost or implementation timelines, considering ABRPL would be the first second-generation (2G) bio-refinery to be set up in India; successful implementation of this project within the desired timelines would be a key monitorable. 

 

The rating continues to reflect the strategic importance this project holds to, and the expectations of continuous support it receives from Numaligarh Refinery Limited (NRL; rated ‘CRISIL AAA/Stable/CRISIL A1+’). NRL continues to hold 50% shareholding in this company with a 75% economic interest and is expected to continue with a similar shareholding structure. It has also provided land for the project on a lease basis to ABRPL. Additionally, NRL would be guaranteeing 100% offtake of the entire bioethanol produced, which would then be blended with the motor spirit it produces; and accordingly, the offtake risk would be low. Further, NRL would also be assisting ABRPL in guaranteeing the offtake/take up the responsibility of marketing the entire furfuryl alcohol produced. The rating also continues to take comfort from the vast experience of the promoters in successfully implementing projects in the oil and gas and energy sector.

 

These strengths are, however, partially offset by the construction progress of the project. ABRPL would be the first 2G bio-refinery to be set up in India and accordingly successful implementation of the project within the desired timelines would be a key monitorable. While the technology, to be licensed by Chempolis Oy (Chempolis), has been tested on a pilot plant basis, its deployment on a commercial scale is still to be seen. The key feedstock i.e. bamboo is abundantly available in the north-eastern regions wherein ABRPL would be setting up its refinery. However, considering the unorganised nature of the segment, seamless execution of bamboo sourcing agreements with the local level entrepreneurs (LLEs) guaranteeing its availability at reasonable price would be a key rating monitorable.

Analytical Approach

CRISIL Ratings has applied its parent notch-up framework to factor in the extent of support the company receives from NRL. While NRL is expected to continue to hold 50% shareholding under the joint venture (JV) structure, at present it holds a 75% economic interest in the project through the additional funding committed through shareholder loans which is unsecured and sub-ordinated to bank loans. Also, considering the strategic importance the project holds for NRL, the company is expected to continue receiving the required operational, financial and managerial support, in a timely manner.

Key Rating Drivers & Detailed Description

Strengths:

  • Strategic importance to JV sponsors i.e. NRL and Fortum 3 BV (Fortum):

ABRPL’s bio-ethanol plant would be of strategic importance to NRL’s existing operations. NRL would be blending the bio-ethanol purchased from ABRPL with the motor spirit it produces, to adhere to the government’s guidelines of achieving a 20% ethanol blending target by 2025. Successful commissioning of the plant would enable Fortum to expand its market reach in the bio-based solutions.

 

The project is expected to receive the required managerial, financial and operational support from its promoters, on a timely basis. There are six directors on the board, out of which three are from NRL, two from Fortum and one from Chempolis; while the Chairman of the board will be alternated between NRL and Fortum’s management, every 5 years.

 

NRL has also been closely providing the required operational support on grounds such as manpower resources and utilities, to ensure seamless execution of the project. The bio-refinery would be set up adjacent to NRL’s existing refinery, on the land leased by NRL.

 

  • Comfortable DSCR position expected owing to assured offtake:

NRL would be guaranteeing the entire offtake of the bioethanol produced by ABRPL. It would also be ensuring the offtake of furfuryl alcohol produced, in case ABRPL is unable to market the same. Sale of bioethanol and furfuryl alcohol is expected to contribute to 80-85% of revenues. The offtake agreement will be executed with NRL prior to the plant achieving its commercial operation date (COD) and accordingly its timely execution would be a key rating monitorable.

 

Despite the increase in project cost, DSCR position is expected to remain comfortable with an average DSCR of around 1.4 times, expected over the tenure of the loan. Since the cost escalations have mainly been due to changes in project scope which would yield incremental profits, no major impact on the debt servicing ability of the company is expected.

 

Weaknesses:

  • Susceptibility to time and cost overruns, thereby impacting economic viability of the project

Construction of the bio-refinery begun in early 2019, wherein the plant was expected to commission by April 2022. However, requirement to undertake certain changes in the project scope coupled with the execution delays that were faced due to the Covid-19 pandemic has delayed the plant’s expected commissioning date to April 2023.

 

A comfort is taken of the vast experience of the promoters who have depicted a suitable track record in successfully implementing projects in the oil and gas and energy sector. However, this being the first 2G bio-refinery to be set up in India, its steady execution as per the planned timelines as well as its successful commissioning would continue to be a key rating monitorable.

 

  • Operating margins could be exposed to volatility in feedstock prices

Bio-ethanol prices are regulated by the government, wherein currently the minimum support price is being estimated basis the cost of production of ethanol as a co-product in sugar mills. The current mechanism therefore considers the sugarcane prices while arriving at the minimum support price (MSP) for bio-ethanol. On the other hand, ABRPL would be processing bamboo to produce ethanol and therefore, the product prices would be delinked to feedstock prices. Accordingly, post the plant commissioning its operations, the ability of the company to maintain its operating margins amidst the fluctuations that could arise in the feedstock prices, would be a key rating monitorable.

Liquidity: Adequate

The project is currently being funded through a mix of equity and debt, as per the funding terms agreed upon. External funding required has been tied up via term debt, balance to be funded via quasi equity and viability gap funding of Rs. 150 crore. Repayments for the funded debt is expected to begin one year after the commissioning of plant operations. The project is expected to continue receiving the required funding, on a timely basis, owing to the strong balance sheets of the two JV sponsors namely, NRL and Fortum.

Outlook: Negative

CRISIL Ratings believes that ABRPL’s credit risk profile could be impacted in case the project incurs any further time or cost overruns. ABRPL being the first 2G bio-refinery to be set up in India, its successful implementation within the desired timelines would be closely monitored. 

Rating Sensitivity factors

Upward factors:

  • Timely and successful commissioning of the plant, within the budgeted revised project cost
  • Execution of the required bamboo sourcing and offtake agreements, wherein a comfortable DSCR of 1.40 times could be expected over the loan tenure

 

Downward factors:

  • Considerable delay in project execution, resulting in significant time and cost overruns
  • Sharp uptick in bamboo prices or unfavorable realisation of bioethanol produced, resulting in DSCR weakening to below 1.30 times
  • Downward revision in credit rating of NRL by at least one notch
  • Reduction in shareholding or moderation in support philosophy of NRL towards ABRPL

About the Company

Incorporated in June 2018, ABRPL is a joint venture set up by NRL, Fortum 3 BV and Chempolis Oy, wherein NRL would hold a 50% equity stake while Fortum 3 BV and Chempolis together would hold the remaining 50%. The company has been set up with an aim to produce eco-friendly bio-ethanol from bamboo biomass, along with the other co-products namely furfuryl alcohol, acetic acid and liquid CO2.

 

Construction of the bio-refinery began in early 2019, wherein the plant was expected to commission by April 2022. However, requirement to undertake certain changes in the project scope coupled with the execution delays that were faced due to the Covid-19 pandemic has delayed the plant’s expected commissioning date to April 2023.

 

Through processing 300,000 tonned per annum (TPA) of dry bamboo (500,000 TPA of green bamboo), ABRPL would be able to produce 50,120 TPA of bio-ethanol (48,900 TPA expected initially), 11,100 TPA of acetic acid and 18,600 TPA of furfuryl alcohol annually. Also, a total of 31,680 metric tonne of liquid CO2 will be extracted from off-gas streams annually, as identified as per the changes in project scope recently undertaken.

 

The project cost which initially was estimated at Rs 1750 crore, has been revised to Rs 3250 crore. The total project cost is estimated to be funded in the debt: equity ratio of 67:33. The Rs 150 crore of viability gap funding that the company is entitled to receive is considered as a quasi-equity for computing the funding mix.

Key Financial Indicators*

As on / for the period ended March 31

 

2022

2021

Operating income

Rs crore

NA

NA

Reported profit after tax (PAT)

Rs crore

NA

NA

PAT margin

%

NA

NA

Adjusted debt/adjusted networth

Times

NA

NA

Interest coverage

Times

NA

NA

*Company is in project stage

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings' complexity levels are assigned to various types of financial instruments. The CRISIL Ratings' complexity levels are available on www.crisil.com/complexity-levels. Users are advised to refer to the CRISIL Ratings' complexity levels for instruments that they consider for investment. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of instrument

Date of allotment

Coupon

Rate (%)

Maturity

date

Issue size

(Rs crore)

Complexity

level

Rating assigned

with outlook

NA

Rupee Term Loan

NA

MCLR + 0.95%

30-Sep-33

1225.00

NA

CRISIL A+/Negative

NA

Rupee Term Loan

NA

MCLR + 0.95%

30-Sep-33

945.00

NA

CRISIL A+/Negative

 

Annexure - Rating History for last 3 Years
  Current 2022 (History) 2021  2020  2019  Start of 2019
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities LT 2170.0 CRISIL A+/Negative 05-01-22 CRISIL A+/Negative   -- 05-10-20 CRISIL A+/Stable   -- --
All amounts are in Rs.Cr.
Annexure - Details of Bank Lenders & Facilities
Facility Amount (Rs.Crore) Name of Lender Rating
Rupee Term Loan 1225 Punjab National Bank CRISIL A+/Negative
Rupee Term Loan 945 Punjab National Bank CRISIL A+/Negative

This Annexure has been updated on 04-Aug-22 in line with the lender-wise facility details as on 30-Jul-21 received from the rated entity.

Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating Criteria for Petrochemical Industry
Criteria for Notching up Stand Alone Ratings of Companies based on Parent Support

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Manish Kumar Gupta
Senior Director
CRISIL Ratings Limited
B:+91 124 672 2000
manish.gupta@crisil.com


Nitesh Jain
Director
CRISIL Ratings Limited
D:+91 22 3342 3329
nitesh.jain@crisil.com


Vinit Patil
Senior Rating Analyst
CRISIL Ratings Limited
B:+91 22 3342 3000
Vinit.Patil@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 

 



About CRISIL Limited

CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks and leading corporations.

CRISIL is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.


For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL’s privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale (‘report’) that is provided by CRISIL Ratings Limited (‘CRISIL Ratings’). To avoid doubt, the term ‘report’ includes the information, ratings and other content forming part of the report. The report is intended for the jurisdiction of India only. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. In preparing our report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. The rating contained in the report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way. CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains.

Neither CRISIL Ratings nor its affiliates, third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively, ‘CRISIL Ratings Parties’) guarantee the accuracy, completeness or adequacy of the report, and no CRISIL Ratings Party shall have any liability for any errors, omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the report. EACH CRISIL RATINGS PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any), are made available on its website, www.crisilratings.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and/or relies on in its reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For details please refer to:
https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public website, www.crisilratings.com. For latest rating information on any instrument of any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301.

This report should not be reproduced or redistributed to any other person or in any form without prior written consent from CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings is a wholly owned subsidiary of CRISIL Limited.

 

 

CRISIL Ratings uses the prefix ‘PP-MLD’ for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisil.com/en/home/our-businesses/ratings/credit-ratings-scale.html